Image Guided Radiotherapy Market

Image Guided Radiotherapy Market Outlook

The global image-guided radiotherapy market size is expected to surge significantly and approach USD 1.9 billion in 2024.

The demand for image-guided radiotherapy is anticipated to thrive at a strong 14.7% CAGR between 2024 and 2034. The image-guided radiotherapy sales revenue is envisioned to surpass USD 7.4 billion by 2034.

One of the main factors expected to accelerate the growth of the image-guided radiotherapy (IGRT) market is the rising incidence of cancer and the quick advancements in cancer treatment. The demand for image-guided radiation therapy (IGRT) is anticipated to be stimulated by the increasing number of older adults and cancer patients worldwide.

The IGRT market has the potential to expand due to industry improvements in technology and the increasing acceptance of various radiotherapy equipment and methods. Increased public understanding of the benefits of radiation therapy is likely to support the image-guided radiotherapy market.

Attributes	Details
Market Value for 2024	USD 1.9 billion
Market Value for 2034	USD 7.4 billion
Market CAGR from 2024 to 2034	14.7%

Impelling Factors Energizing the Image-guided Radiotherapy Market

• The development of imaging technologies like cone-beam CT, MRI, and PET is a continuing factor in the ongoing enhancement of image-guided radiotherapy systems. These advancements compel the image-guided radiotherapy market by improving real-time tracking capabilities and image quality.
• The IGRT market is expanding due to government and healthcare organization financing, initiatives, and supportive policies to enhance cancer care and treatment outcomes.
• The widespread adoption of image-guided radiotherapy in clinical practice is facilitated by healthcare professionals' growing knowledge of its advantages, particularly radiation oncologists.
• Many patients are looking for cutting-edge, less invasive therapy alternatives. The adoption of image-guided radiotherapy is driven by the need for therapies that provide better outcomes, decrease adverse effects, and increase precision.
• Radiotherapy's overall effectiveness is increased when it can be adjusted in real-time to account for daily alterations in the architecture and position of the tumor. With the adoption of IGRT, the cancer is regularly exposed to the recommended radiation dose.

Attributes	Details
Market Value for 2019	USD 0.9 billion
Market Value for 2023	USD 1.6 billion
Market CAGR from 2019 to 2023	17.1%

Bottlenecks Inhibiting the Expansion of Image Guided Radiotherapy Sector

• IGRT technologies and other cutting-edge healthcare facilities are typically found in developed areas. Inaccessible locations in underdeveloped nations or isolated regions are likely to contribute to differences in the outcomes of cancer treatments and impede the image-guided radiotherapy market expansion.
• Companies operating in the image-guided radiotherapy industry face difficulties due to strict regulations and differences in regulatory standards among various areas. Searching complicated regulatory environments might delay getting a product approved and entering the image-guided radiation therapy (IGRT) market.
• Healthcare personnel receive specialized training to adopt image-guided radiation therapy, which requires complex technology. Widespread adoption of image-guided radiotherapy is impeded by the lengthy learning curve caused by the intricacy of using and understanding data from imaging equipment.

Category-wise Outlook

The segmented market analysis of image-guided radiotherapy is included in the following subsection. Based on comprehensive studies, the soft-tissue imaging sector is leading the type category, and the radiation-based segment is commanding the technology category.

Soft-tissue Imaging's Commanding Presence in Image Guided Radiotherapy Sales

Attributes	Details
Top Types	Soft-Tissue Imaging
CAGR % 2019 to 2023	16.8%
CAGR % 2024 to End of Forecast (2034)	14.5%

• Soft-tissue imaging dominates image-guided radiotherapy sales because of its critical role in accurate tumor localization, making tailored radiation therapy possible.
• Soft-tissue imaging provides a wide range of applications in image-guided radiotherapy, covering a broad spectrum of cancer types and guaranteeing broad commercial appeal.
• The potential of soft-tissue imaging to effectively visualize anatomical features to support doctors in treatment planning and adaptation propels the demand for image-guided radiotherapy.
• Soft-tissue imaging is becoming increasingly vital, strengthening its place as the main source of image-guided radiotherapy market revenue. This is due to the increased focus on customized and targeted cancer therapies.

Advancements in Radiation-Based Technology Spurring Market Preference

Attributes	Details
Top Technology	Radiation-Based
CAGR % 2019 to 2023	16.4%
CAGR % 2024 to End of Forecast (2034)	14.1%

• Sustained progress in radiation-based technology guarantees a competitive advantage, propelling consumer inclination and increasing revenue.
• Healthcare professionals opt for radiation-based systems because of their demonstrated efficacy and dependability.
• Radiation-based methods let doctors plan adaptive treatments by offering detailed information on tumor response.
• Radiation-based technologies with advanced imaging capabilities allow for real-time tumor visualization, which maximizes therapy delivery.

Country-wise Analysis

Tables highlighting important economies such as South Korea, the United Kingdom, Japan, China, and the United States demonstrate the landscape of the image-guided radiotherapy industry.

The significant potential is revealed by a thorough investigation in South Korea, which offers plenty of opportunities for image-guided radiotherapy market expansion.

South Korea has an upward trajectory in the image-guided radiotherapy industry, which calls for more research and investment. These factors include technology breakthroughs, healthcare infrastructure, and regulatory frameworks.

The Rapid Integration of Image-guided Radiotherapy in South Korea

Attribute	South Korea
HCAGR (2019 to 2023)	22.3%
CAGR (2024 to 2034)	16.6%

• Increasing awareness of precision treatment and an improved healthcare infrastructure have led to a growing pattern of image-guided radiotherapy adoption in South Korea.
• South Korea image-guided radiation therapy market is expected to reach USD 465.4 million by 2034.
• Government programs in South Korea facilitate the rapid adoption of image-guided radiotherapy into oncology procedures that highlight technological improvements in cancer care.
• The adoption of image-guided radiotherapy is motivated by the considerable emphasis on medical tourism in South Korea, which draws patients seeking advanced oncological therapies.

Image-guided Radiotherapy Enhances Cancer Treatment Quality in the United Kingdom

Attribute	United Kingdom
HCAGR (2019 to 2023)	19.6%
CAGR (2024 to 2034)	15.7%

• Driven by a holistic approach to cancer treatment innovation, the United Kingdom is at the forefront of incorporating image-guided radiotherapy into its healthcare system.
• By 2034, the image-guided radiotherapy market in the United Kingdom is likely to be worth USD 294 million.
• The adoption of image-guided radiotherapy is a top priority in the United Kingdom's national health policies to improve the effectiveness and caliber of cancer care services.
• The broad acceptance of image-guided radiation therapy, which emphasizes individualized and precise treatment plans, is a reflection of the United Kingdom's dedication to lowering cancer deaths.

Image-guided Radiotherapy's Role in Japan's Oncology Landscape

Attribute	Japan
HCAGR (2019 to 2023)	19.3%
CAGR (2024 to 2034)	15.5%

• The demand for image-guided radiotherapy in delivering focused and effective oncological therapies is highlighted by Japan's aging population and rising cancer rate.
• The rigorous planning and execution of image-guided radiotherapy ensure the best treatment outcomes for patients, which aligns with the Japanese culture's emphasis on precision and attention to detail.
• By 2034, the demand for image-guided radiotherapy in Japan is anticipated to be estimated at USD 755.3 million.
• Innovative medical technology is embraced by the Japanese regulatory environment, which accelerates the adoption of image-guided radiotherapy treatments.

China's Accelerated Adoption of Image-guided Radiotherapy

Attribute	China
HCAGR (2019 to 2023)	18.9%
CAGR (2024 to 2034)	15.1%

• Image-guided radiotherapy adoption is increasing in China, owing to the government's emphasis on improving healthcare infrastructure and enhancing cancer treatment capabilities.
• China's demand for image-guided radiotherapy is forecasted to climb to USD 1.1 billion by 2034.
• Rapid urbanization in China raises awareness and opportunities for image-guided radiotherapy, particularly in big cities with established healthcare facilities.
• China's dedication to treating cancer's rising prevalence coincides with the broad adoption of image-guided radiotherapy, which provides a critical tool for accurate and effective cancer treatment.

Image-Guided Radiotherapy's Evolutionary Journey in the United States

Attribute	United States
HCAGR (2019 to 2023)	17.6%
CAGR (2024 to 2034)	14.9%

• The United States is recognized as a global leader in cancer care innovation due to its strong ecosystem of research and development that fosters the ongoing advancement of image-guided radiotherapy.
• The image-guided radiotherapy market in the United States is scheduled to be worth about USD 1.3 billion by 2034.
• To maximize results, the healthcare system in the United States strongly emphasizes individualized treatment programs, with image-guided radiotherapy as a key component.
• Image-guided radiotherapy technologies are advancing quickly due to vendor rivalry and innovation fueled by strict regulatory standards and a competitive healthcare industry.

Competitive Analysis

Numerous significant image-guided radiotherapy (IGRT) vendors stand out as essential contributors to innovation and development in the highly competitive market.

Prominent image-guided radiotherapy suppliers leading the way include ViewRay, General Electric Company, Hitachi, Ltd., Siemens AG, and Koninklijke Philips N.V.

The image-guided radiotherapy providers have come to be recognized as industry leaders, advancing the development of image-guided radiotherapy technology and establishing the bar for dependability and creativity.

With its advanced offerings, ViewRay faces against General Electric Company, a well-established leader recognized for its proficiency in medical imaging technologies.

Hitachi, Ltd. offers the market a wealth of knowledge and technological know-how, while Siemens AG and Koninklijke Philips N.V. provide their creative solutions for image-guided radiotherapy.

The substantial image-guided radiotherapy vendors contribute to the continuous advancement of IGRT technology by bringing unique skills and capacities to the competition scene. They ensure that the image-guided radiotherapy (IGRT) market remains competitive and dynamic by investing in research and development and being dedicated to fulfilling the changing demands of patients and healthcare professionals.

By establishing their status as leading image-guided radiotherapy (IGRT) providers, the industry leaders are navigating the market challenges and setting the path for ongoing technological and patient care breakthroughs.

Notable Breakthroughs

Company	Details
Philips	Philips launched Zenition 10 in May 2023, adding to their line of mobile C-arms.
GE HealthCare	The introduction of Pixxoscan in April 2023 marked a portfolio expansion for GE HealthCare's magnetic resonance imaging (MRI) contrast agents. Clariscan (gadoteric acid) and Pixxoscan (gadobutrol), two of many prominent macrocyclic compounds, are accessible to customers.
GE HealthCare	GE HealthCare revealed plans in June 2023 to integrate AIR technology into its PET/MR capabilities to enhance patient comfort, simplify therapy evaluation, and increase diagnostic accuracy.
National Medical Products Administration (NMPA)	ViewRay's MRIdian MRI-guided radiation therapy system was authorized for sale and usage in September 2022 by the National Medical Products Administration (NMPA), China's regulatory body.

Vital Image Guided Radiotherapy Providers

• ViewRay
• General Electric Company
• Hitachi, Ltd.
• Siemens AG
• Koninklijke Philips N.V.

Key Coverage in Image Guided Radiotherapy Market Report

• Categorical Study on Radiation-Based, and Non-Radiation Based Systems
• Image Guided Radiotherapy Market Detailed Analysis of Current Scenario with Growth Forecasts
• Market Opportunities for Image Guided Radiotherapy is South Korea
• Market Potential of Image Guided Radiotherapy in the United Kingdom
• Competition Analysis of Image Guided Radiotherapy Industry with Focus on Philips, and GE HealthCare

Key Segments

By Type:

• Soft-Tissue Imaging
• Lung Mri
• Simplifying Cardiac Mri
• Simplifying Mri-Conditional Implant Scans
• Silent Mri Scanning

By Technology:

• Radiation-Based
• Non-Radiation Based Systems

By Devices:

• X-Ray Computed Tomography (Ct)
• Magnetic Resonance Imaging (Mri)
• Positron Emission Tomography

By End Users:

• Hospitals
• Smart Cancer Centers
• Research Institutes

By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Frequently Asked Questions

What is Current Image Guided Radiotherapy Market Valuation?

The image guided radiation therapy market to secure a valuation USD 1.9 billion in 2024.

How Big Can the Image Guided Radiotherapy Market Be by 2034?

The image guided radiation therapy market is estimated to attain a worth of USD 7.4 billion by 2034.

What is the Growth Potential of the Image Guided Radiotherapy Market?

Through 2034, the image guided radiation therapy market is anticipated to strengthen at a 14.7% CAGR.

What Was the Historical Outlook of The Image Guided Radiotherapy Market?

From 2019 to 2023, the image guided radiation therapy market recorded a 17.1% CAGR.

Which Types Segment to Dominate in the Image Guided Radiotherapy Market?

From 2024 to 2034, the soft-tissue imaging sector is projected to flourish at a 14.5% CAGR.

Which Technology Segment to Lead the Image Guided Radiotherapy Market?

The radiation-based sector is envisioned to develop at a 14.1% CAGR from 2024 to 2034.